Stifel Reiterates Buy Rating on WAVE Life Sciences (WVE), Believes "Caution is Warranted with WVE-004" Despite Favorably Looking Top-Line Data
Tweet Send to a Friend
Stifel analyst Paul Matteis reiterated a Buy rating on WAVE Life Sciences (NASDAQ: WVE), following the company's report of initial ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
